Real-World Evidence for Long-Term Safety and Effectiveness of Ipragliflozin in Japanese Patients with Type 2 Diabetes Mellitus: final Results of a 3-Year Post-Marketing Surveillance Study (STELLA-LONG TERM)

Ichiro Nakamura^*, Hiroshi Maegawa, Kazuyuki Tobe, Satoshi Uno

^*この論文の責任著者

内科学（第一）講座

研究成果: ジャーナルへの寄稿 › 学術論文 › 査読

フィンガープリント

「Real-World Evidence for Long-Term Safety and Effectiveness of Ipragliflozin in Japanese Patients with Type 2 Diabetes Mellitus: final Results of a 3-Year Post-Marketing Surveillance Study (STELLA-LONG TERM)」の研究トピックを掘り下げます。これらがまとまってユニークなフィンガープリントを構成します。

並べ替え順
重み付け
アルファベット順

Real-World Evidence for Long-Term Safety and Effectiveness of Ipragliflozin in Japanese Patients with Type 2 Diabetes Mellitus: final Results of a 3-Year Post-Marketing Surveillance Study (STELLA-LONG TERM)

フィンガープリント

Keyphrases

Pharmacology, Toxicology and Pharmaceutical Science